<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(12)</volume><submitter>Dermitzakis E</submitter><journal>Brain sciences</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11674050</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Real-World Open-Label Experience with Rimegepant for the Acute Treatment of Migraine Attacks: A Multicenter Pilot Study</pubmed_title><pmcid>PMC11674050</pmcid><pubmed_authors>Dermitzakis E</pubmed_authors><pubmed_authors>Xiromerisiou G</pubmed_authors><pubmed_authors>Zisopoulou S</pubmed_authors><pubmed_authors>Vikelis M</pubmed_authors><pubmed_authors>Rallis D</pubmed_authors><pubmed_authors>Vasiliadis G</pubmed_authors><pubmed_authors>Soldatos P</pubmed_authors><pubmed_authors>Vlachos G</pubmed_authors><pubmed_authors>Rikos D</pubmed_authors><pubmed_authors>Argyriou A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Real-World Open-Label Experience with Rimegepant for the Acute Treatment of Migraine Attacks: A Multicenter Pilot Study</name><description/><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2025-04-04T01:33:02.396Z</modification><creation>2025-04-04T01:33:02.396Z</creation></dates><accession>S-EPMC11674050</accession><cross_references/></HashMap>